Zdrowie i gospodarka · 27/12/2022
FDA Classifies Human Leukocyte Antigen Typing Companion Diagnostic Test into Class II Special Controls
The FDA is classifying the human leukocyte antigen typing companion diagnostic test into Class II, special controls, to ensure safety and effectiveness, and enhance patient access to innovative devices.
Source: Federal Register — Food and Drug AdministrationOpen original release →